Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization

Haissaguerre, Michel; Sacher, Frederic; Nogami, Akihiko; Heidbuchel, Hein; et al.

doi:10.1016/J.JACC.2008.10.044

Title

Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization

Author

Haissaguerre, Michel

Sacher, Frederic

Nogami, Akihiko

Heidbuchel, Hein

et al.

Abstract

Objectives Our purpose was to evaluate the efficacy of antiarrhythmic drugs (AADs) in recurrent ventricular fibrillation (VF) associated with inferolateral early repolarization pattern on the electrocardiogram. Background Although an implantable cardioverter-defibrillator is the treatment of choice, additional AADs may be necessary to prevent frequent episodes of VF and reduce implantable cardioverter-defibrillator shock burden or as a lifesaving therapy in electrical storms. Methods From a multicenter cohort of 122 patients (90 male subjects, age 37 +/- 12 years) with idiopathic VF and early repolarization abnormality in the inferolateral leads, we selected all patients with more than 3 episodes of VF (multiple) including those with electrical storms (>= 3 VF in 24 h). The choice of AAD was decided by individual physicians. Follow-up data were obtained for all patients using monitoring with implantable defibrillator. Successful oral AAD was defined as elimination of all recurrences of VF with a minimal follow-up period of 12 months. Results Multiple episodes of VF were observed in 33 (27%) patients. Electrical storms (34 +/- 47 episodes) occurred in 16 and were unresponsive to beta-blockers (11 of 11), lidocaine/mexiletine (9 of 9), and verapamil (3 of 3), while amiodarone was partially effective (3 of 10). In contrast, isoproterenol infusion immediately suppressed electrical storms in 7 of 7 patients. Over a follow-up of 69 +/- 58 months, oral AADs were poorly effective in preventing recurrent VF: beta-blockers (2 of 16), verapamil (0 of 4), mexiletine (0 of 4), amiodarone (1 of 7), and class 1C AADs (2 of 9). Quinidine was successful in 9 of 9 patients, decreasing recurrent VF from 33 +/- 35 episodes to nil for 25 +/- 18 months. In addition, quinidine restored a normal electrocardiogram. Conclusions Multiple recurrences of VF occurred in 27% of patients with early repolarization abnormality and may be life threatening. Isoproterenol in acute cases and quinidine in chronic cases are effective AADs. (J Am Coll Cardiol 2009; 53: 612-9) (C) 2009 by the American College of Cardiology Foundation

Language

English

Source (journal)

Journal of the American College of Cardiology. - New York, N.Y.

Publication

New York, N.Y. : 2009

ISSN

0735-1097

DOI

10.1016/J.JACC.2008.10.044

Volume/pages

53 :7 (2009) , p. 612-619